The aim of this study was to test whether sAβ and fAβ differentially regulate the expression of a subset of 9 miRNAs that was previously reported to be aberrantly expressed in AD or was well-demonstrated in the regulation of synaptic plasticity, inflammation, apoptosis, or mitochondrial activity. The gene discussed is SH3BP5; the disease is Alzheimer disease.